Reductive debromination of (α-bromoiso-valeryl)urea by intestinal bacteria

被引:8
作者
Kitamura, S [1 ]
Kuwasako, M [1 ]
Ohta, S [1 ]
Tatsumi, K [1 ]
机构
[1] Hiroshima Univ, Sch Med, Inst Pharmaceut Sci, Minami Ku, Hiroshima 7348551, Japan
关键词
D O I
10.1211/0022357991771999
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The reductive debromination of the hypnotic (alpha-bromoiso-valeryl)urea to (3-methylbutyryl)urea by intestinal bacteria has been studied. The caecal contents of rats, mice, hamsters, guinea-pigs and rabbits had significant debrominating activity toward (alpha-bromoiso-valeryl)urea. The cell-free extract of intestinal bacteria from the caecal contents of rats had debrominating activity in the presence of both flavin mononucleotide (FMN) and NADH (or NADPH) under anaerobic conditions. Seven pure strains of intestinal bacteria were also tested and the highest activity was observed with Clostridium sporogenes. The cell-free extract of Clostridium sporogenes had debrominating activity in the presence of both FMN and NADH (or NADPH), and this activity was inhibited by sodium arsenite and potassium cyanide. The activity of the cell-free extract was also supported by the photochemically reduced form of FMN. The debromination in intestinal bacteria seems to proceed in two steps-reduction of flavins by bacterial flavin reductase(s) in the presence of NADPH or NADH, and then the reductive debromination of (alpha-bromoiso-valeryl)urea to (3-methylbutyryl)urea by bacterial dehalogenase(s) using the reduced flavins as an electron donor. These results indicate that intestinal bacteria play a role in the reductive debromination of (alpha-bromoiso-valeryl)urea to (3-methylbutyryl)urea in animals. The debromination is inhibited by oxygen and dependent on flavins.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 33 条
[1]   THE MECHANISM OF REDUCTIVE DEHALOGENATION OF HALOTHANE BY LIVER CYTOCHROME-P450 [J].
AHR, HJ ;
KING, LJ ;
NASTAINCZYK, W ;
ULLRICH, V .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (03) :383-390
[2]   THE EFFECT OF VARYING HALOGEN SUBSTITUENT PATTERNS ON THE CYTOCHROME-P450 CATALYZED DEHALOGENATION OF 4-HALOGENATED ANILINES TO 4-AMINOPHENOL METABOLITES [J].
CNUBBEN, NHP ;
VERVOORT, J ;
BOERSMA, MG ;
RIETJENS, IMCM .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (09) :1235-1248
[3]   METABOLISM OF INSECTICIDES BY REDUCTIVE SYSTEMS [J].
ESAAC, EG ;
MATSUMURA, F .
PHARMACOLOGY & THERAPEUTICS, 1980, 9 (01) :1-26
[4]   The mechanism and substrate specificity of the NADPH:flavin oxidoreductase from Escherichia coli [J].
Fieschi, F ;
Niviere, V ;
Frier, C ;
Decout, JL ;
Fontecave, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30392-30400
[5]  
GINGELL R, 1971, Xenobiotica, V1, P143
[6]  
HAYASHIDA H, 1985, JPN J LEGAL MED, V39, P539
[7]  
Ishida M, 1996, BIOCHEM MOL BIOL INT, V39, P1157
[8]  
ISONO H, 1975, J HYG CHEM, V21, P188
[9]  
ISONO H, 1978, J HYG CHEM, V24, P5
[10]   THIOL STIMULATION OF THE CYTOCHROME-P-450-DEPENDENT REDUCTION OF 1,1,1-TRICHLORO-2,2-BIS(PARA-CHLOROPHENYL)ETHANE (DDT) TO 1,1-DICHLORO-2,2-BIS(PARA-CHLOROPHENYL)ETHANE (DDD) [J].
KELNER, MJ ;
MCLENITHAN, JC ;
ANDERS, MW .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (11) :1805-1807